He was referred to haematology for treatment and following cycle 4 of chemotherapy, a follow up Computed Tomography scan of his Chest, Abdomen and Pelvis showed a significant reduction in size of the Primary Pancreatic Lymphoma.
DISCUSSION
Primary Pancreatic Lymphoma (PPL) is a rare subtype of primary pancreatic malignancy, consisting of <0.5% of all pancreatic cancers), usually found in males aged 35-75.
1,2
The diagnostic criteria for PPL are: 1) Neither superficial lymphadenopathy nor enlargement of mediastinal lymph nodes on chest radiography.
2) Normal leucocyte count in peripheral blood.
3) Main mass in the pancreas with lymph-nodal involvement confined to the peri-pancreatic region.
4) No hepatic or splenic involvement.

3
They present in similar ways to the head of pancreas adenocarcinoma, with symptoms such as jaundice, pancreatitis, abdominal pain, abdominal mass and diarrhoea, though rarely have typical B-symptoms of Non-Hodgkin's Lymphoma such as night sweats or fevers.
2
Serum tumour markers are not particularly useful in PPL as they are not always raised, and CT scan can confirm presence of distal node involvement therefore pointing away from a PPL.
Endoscopic ultrasound (EUS) combined with fine needle biopsy (FNB) improves diagnostic accuracy on top of an FNA alone.
2 EUS is less invasive and can characterise the lesions present. Once a FNB has been obtained from EUS, it will be sent for Flow Cytometry (FC) and immunohistochemistry in order to aid diagnosis and treatment.
The treatment for PPL is cycles of chemotherapy under the guidance of a haematologist, without evidence for surgical resection. 4 The prognosis for PPL is much better than that for pancreatic adenocarcinoma. A case series from 2005 showed a mean survival rate of 69-80 months for patients who received chemotherapy as a first line treatment for PPL.
5
CONCLUSION
As shown in this case, histological sampling of a pancreatic mass must always be made given the difference in treatment and prognosis between adenocarcinoma and PPL. Given the small amount of tissue involved, samples should be sent for immunohistochemistry and flow cytometry to aid diagnosis and treatment. 
FEASIBILITY OF COLOUR DOPPLER ULTRASOUND FOR DETECTION OF INTRAARTICULAR SACROILIAC JOINT INJECTION: A CASE SERIES.
Editor,
We would like to share our experience of colour Doppler ultrasound (CDU) in the detection of correct needle placement for sacroilliac joint (SIJ) injection during interventional procedures for management of low back pain (LBP).
Injection of steroid mixed with local anaesthetic (LA) is a well-recognised method for both diagnostic and therapeutic management of SIJ pain. Several imaging modalities have been used to guide such interventions in SIJ. 1 Fluoroscopic guidance is still considered as gold standard to confirm needle placement and spread of the dye. The majority of such imaging techniques involve use of ionising radiation. Ultrasound is however being used increasingly.
2 In many interventional pain procedures it is replacing ionising modalities because of the portability allowing the procedure to be performed at bedside without such hazards. 3 However, ultrasound has ta potential limitation in viewing the needle trajectory and the spread of the injectate inside the bony SIJ. CDU can overcome this problem by allowing visualisation of the flow of the injectate. 4 We thus decided to conduct this case study to find out the utility of CDU. After obtaining approval from ethical committee and informed consent, 10 adult patients scheduled to undergo SIJ injection were included. After positioning the patients in prone position and using proper aseptic cleaning and draping, a low frequency curvilinear ultrasound transducer was used to localise the target SIJ anatomy. After skin infiltration with LA, a 22-gauge Quincke spinal needle was advanced towards the SIJ under ultrasound guidance. Once the needle was seen to enter the SIJ, colour Doppler mode was activated. A 1.5 mL mixture of steroid and LA was then injected. Positve Doppler signal suggesting the flow within the SIJ along with absence of any overflow outside the bony landmarks were noted (Fig  1) . Then an independent observer who was blinded about the study methodology, confirmed the intra-articular placement of the needle fluoroscopically by injecting radioopaque contrast. Efficacy of the injection in providing pain relief, was assessed at follow up.
Demographic details of the patients are depicted in Table 1 . CDU flow pattern indicated correct intra-articular injection without any extra-articular flow pattern in all our patients. Subsequent fluoroscopy and dye injection also confirmed correct needle placement. Preprocedural visual analog score (VAS) (6.7±1.05) reduced significantly after the injection (2.3±1.03) (p <0.0001) ( Table 2 ) confirming the efficacy of the procedure.
In this case series, we found that CDU can be used successfully to confirm correct intra-articular placement of needle and subsequent injectate in SIJ.
This utility of CDU has not been reported to date. Arslan et al. used duplex and colour Doppler ultrasound to demonstrate vascularity inside and around the SIJ to diagnose sacroilitis and to monitor the therapeutic response, but they did not perform any SIJ injection using ultrasound. We thus strongly propose a well powered randomised controlled trial on this.
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Fig 1:
Use of color Doppler flow to locate needle placement.
